Suppr超能文献

相似文献

1
Spice drugs are more than harmless herbal blends: a review of the pharmacology and toxicology of synthetic cannabinoids.
Prog Neuropsychopharmacol Biol Psychiatry. 2012 Dec 3;39(2):234-43. doi: 10.1016/j.pnpbp.2012.04.017. Epub 2012 Apr 26.
2
4
Spicing things up: synthetic cannabinoids.
Psychopharmacology (Berl). 2013 Aug;228(4):525-40. doi: 10.1007/s00213-013-3188-4. Epub 2013 Jul 9.
5
Beyond THC: The New Generation of Cannabinoid Designer Drugs.
Front Behav Neurosci. 2011 Sep 21;5:60. doi: 10.3389/fnbeh.2011.00060. eCollection 2011.
7
"Legal highs" - new players in the old drama.
Curr Drug Abuse Rev. 2011 Jun;4(2):122-30. doi: 10.2174/1874473711104020122.
8
The impact of changes in UK classification of the synthetic cannabinoid receptor agonists in 'Spice'.
Int J Drug Policy. 2011 Jul;22(4):274-7. doi: 10.1016/j.drugpo.2011.02.006. Epub 2011 Apr 8.
9
Synthetic cannabis.
Tidsskr Nor Laegeforen. 2012 Oct 30;132(20):2289. doi: 10.4045/tidsskr.12.0661.

引用本文的文献

1
UK Medical Cannabis Registry: A Clinical Outcomes Analysis for Epilepsy.
Brain Behav. 2025 Apr;15(4):e70490. doi: 10.1002/brb3.70490.
3
Metabolic profiling of the synthetic cannabinoid APP-CHMINACA (PX-3) as studied by in vitro and in vivo models.
Forensic Toxicol. 2025 Jan;43(1):130-141. doi: 10.1007/s11419-024-00705-0. Epub 2024 Nov 22.
4
Rapid screening and identification of novel psychoactive substances using PaperSpray interfaced to high resolution mass spectrometry.
Clin Mass Spectrom. 2016 Sep 28;1:3-10. doi: 10.1016/j.clinms.2016.08.003. eCollection 2016 Nov.
5
Effect of EMB-FUBINACA on brain endothelial cell angiogenesis: Expression analysis of angiogenic markers.
Naunyn Schmiedebergs Arch Pharmacol. 2025 Feb;398(2):1613-1624. doi: 10.1007/s00210-024-03322-1. Epub 2024 Aug 13.
6
Activity-based detection of synthetic cannabinoid receptor agonists in plant materials.
Harm Reduct J. 2024 Jul 1;21(1):127. doi: 10.1186/s12954-024-01044-4.
7
Exploring the topic structure and abuse trends of new psychoactive Substance since the 21st century from a bibliometric perspective.
Saudi Pharm J. 2024 Apr;32(4):101991. doi: 10.1016/j.jsps.2024.101991. Epub 2024 Feb 15.
8
Alternative Crops for the European Tobacco Industry: A Systematic Review.
Plants (Basel). 2024 Jan 15;13(2):236. doi: 10.3390/plants13020236.
9
Abuse of Synthetic Cannabinoids and Cathinones in a Patient on Buprenorphine-Naloxone Treatment: A Case Report.
Cureus. 2023 Nov 6;15(11):e48386. doi: 10.7759/cureus.48386. eCollection 2023 Nov.
10
Shifting drug markets in North America - a global crisis in the making?
Int J Ment Health Syst. 2023 Oct 25;17(1):36. doi: 10.1186/s13033-023-00601-x.

本文引用的文献

2
A major glucuronidated metabolite of JWH-018 is a neutral antagonist at CB1 receptors.
Chem Res Toxicol. 2012 Apr 16;25(4):825-7. doi: 10.1021/tx3000472. Epub 2012 Mar 15.
3
Direct screening of herbal blends for new synthetic cannabinoids by MALDI-TOF MS.
J Mass Spectrom. 2012 Jan;47(1):141-6. doi: 10.1002/jms.2036.
6
Cannabinoids and monoamine neurotransmission with focus on monoamine oxidase.
Prog Neuropsychopharmacol Biol Psychiatry. 2012 Jul 2;38(1):68-77. doi: 10.1016/j.pnpbp.2011.12.010. Epub 2011 Dec 30.
7
Homology modeling of cannabinoid receptors: discovery of cannabinoid analogues for therapeutic use.
Methods Mol Biol. 2012;819:595-613. doi: 10.1007/978-1-61779-465-0_35.
8
Convulsions associated with the use of a synthetic cannabinoid product.
J Med Toxicol. 2012 Mar;8(1):62-4. doi: 10.1007/s13181-011-0182-2.
9
1-Pentyl-3-phenylacetylindoles and JWH-018 share in vivo cannabinoid profiles in mice.
Drug Alcohol Depend. 2012 Jun 1;123(1-3):148-53. doi: 10.1016/j.drugalcdep.2011.11.001. Epub 2011 Nov 27.
10
Designer drugs: a medicinal chemistry perspective.
Ann N Y Acad Sci. 2012 Feb;1248:18-38. doi: 10.1111/j.1749-6632.2011.06199.x. Epub 2011 Nov 17.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验